CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- 4 Open-market sale 10% owner sold 200 shares at $25.19 ($5,038)
- 4 Open-market sale 10% owner sold 2,248 shares at an average $25.10 ($56,433)
- 4 Open-market sale 10% owner sold 3,833 shares at an average $26.33 ($100,910)
- 4 Open-market sale 10% owner sold 25,935 shares at an average $30.48 ($790,612)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 2,343 shares at an average $26.53 ($62,169)
- 4 Open-market sale 10% owner sold 1,595 shares at an average $26.71 ($42,598)
- 4 Open-market sale 10% owner sold 4,330 shares at an average $26.79 ($116,010)
- 4 Open-market sale 10% owner sold 4,804 shares at an average $27.28 ($131,077)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Grant or award Director acquired 26,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 20 · 382 filings